Abrar, Daniel B.
Schleich, Christoph
Nebelung, Sven
Frenken, Miriam
Ullrich, Tim
Radke, Karl Ludger
Antoch, Gerald
Vordenbäumen, Stefan
Brinks, Ralph
Schneider, Matthias
Ostendorf, Benedikt
Sewerin, Philipp
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (NE 2136/3-1).)
Bundesministerium für Bildung und Forschung (01EC1009)
Pfizer Germany (Pfizer GIP Inflammation Germany Research Initiative 2014)
Medizinische Fakultät, Heinrich-Heine-Universität Düsseldorf
Article History
Received: 7 February 2020
Accepted: 14 May 2020
First Online: 29 May 2020
Ethics approval and consent to participate
: The study was approved by the local ethics committee (4962R).
: Written and informed consent was obtained from all patients before the initiation of the study.All authors agreed to the publication of this manuscript.
: The authors declare that they have no competing interests.